PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.\', \'Department of Surgery, Ernest E Moore Shock Trauma Center at Denver Health, Denver, CO, USA.\', \'Department of Surgery, University of Colorado Denver, Aurora, CO, USA.\', \'Department of Medicine, University of Colorado Denver, Aurora, CO, USA.\', \'Department of Pediatrics, Pulmonary Medicine, University of Colorado Denver, Aurora, CO, USA.\', \'Center for Precision Cancer Medicine, Departments of Biological Engineering and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Division of Acute Care Surgery, Trauma and Surgical Critical Care, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/jth.14828
?:doi
?:hasPublicationType
?:journal
  • Journal of thrombosis and haemostasis : JTH
is ?:pmid of
?:pmid
?:pmid
  • 32267998
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all